Reşit Çakmak
Reşit Çakmak publishes mostly in Organic Chemistry, Molecular Biology and Oncology, on topics such as Synthesis and biological activity, Synthesis and Characterization of Heterocyclic Compounds and Metal complexes synthesis and properties.
- World rank
- #1,730,614 of 7,710,434 ranked researchers
- Rank in Türkiye
- #7,767 of 117,622
- Works
- 56
- Citations
- 786
- Citations per work
- 14.0
What does Reşit Çakmak research?
Reşit Çakmak's work is mostly in Chemistry (39%), Medicine (15%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences2545.2%
- Chemistry2239.5%
- Computer Science35.7%
- Everything else1628.1%
- Health Sciences814.6%
- Medicine814.6%
- Life Sciences712.1%
- 1Organic Chemistry36% of their works
- 2Molecular Biology12% of their works
- 3Oncology8% of their works
- 4Pharmacology7% of their works
- 5Computational Theory and Mathematics6% of their works
- 6Spectroscopy4% of their works
Research topics
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Metal complexes synthesis and properties
- Cholinesterase and Neurodegenerative Diseases
- Enzyme function and inhibition
- Computational Drug Discovery Methods
- Free Radicals and Antioxidants
- Analytical Chemistry and Chromatography
Which keywords describe Reşit Çakmak's research?
The keywords of their largest research topics: Anticancer Agents, Medicinal Chemistry, Drug Development, Drug Discovery, Heterocyclic Compounds, Molecular Docking, Tubulin Inhibitors and Synthesis.
- Liquid Chromatography
- Antioxidant
- Inhibitors
- Carbonic Anhydrases
- Acetylcholinesterase
- Cisplatin Resistance
- Synthesis
- Molecular Docking
- Drug Discovery
- Medicinal Chemistry
- Anticancer Agents
- Drug Development
- Heterocyclic Compounds
- Tubulin Inhibitors
- Triazines
- Platinum-Based Drugs
- Cholinesterase Inhibitors
- Drug Target Identification
- Virtual Screening
- Chiral Separation
- Phenolic Compounds
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Anticancer Agents433 topics
- Medicinal Chemistry312 topics
- Drug Development232 topics
- Drug Discovery222 topics
- Heterocyclic Compounds221 topic
- Molecular Docking222 topics
- Tubulin Inhibitors221 topic
- Synthesis131 topic
- Triazines131 topic
- Cisplatin Resistance121 topic
- Platinum-Based Drugs121 topic
- Acetylcholinesterase111 topic
- Cholinesterase Inhibitors111 topic
- Carbonic Anhydrases91 topic
- Drug Target Identification91 topic
- Inhibitors91 topic
- Virtual Screening91 topic
- Antioxidant51 topic
- Chiral Separation51 topic
- Liquid Chromatography51 topic
- Phenolic Compounds51 topic
Where does Reşit Çakmak work?
Reşit Çakmak's main affiliation in the publication record is Batman University, Türkiye.
How many publications and citations does Reşit Çakmak have?
OpenAlex counts 56 works and 786 citations for Reşit Çakmak, an h-index of 18, ranking #1,730,614 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Reşit Çakmak. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.